Inovio Pharmaceuticals (INO) Tax Provisions (2015 - 2019)

Inovio Pharmaceuticals has disclosed Tax Provisions across 3 years of filings, most recently posting -$87764.0 for Q4 2019.

• In Q4 2019, Tax Provisions changed N/A year-over-year to -$87764.0; the TTM figure through Sep 2020 stood at -$87764.0 (up 48.24% YoY), while the FY2019 annual figure was -$257335.0, down 111.86% from the prior year.
• Tax Provisions came in at -$87764.0 for Q4 2019 at Inovio Pharmaceuticals, up from -$106771.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $2.2 million in Q1 2018 to a low of -$1.8 million in Q3 2015.
• Average Tax Provisions over 3 years is -$30881.7, with a median of -$97267.5 recorded in 2019.
• The largest YoY upside for Tax Provisions was 102.89% in 2019 against a maximum downside of 102.89% in 2019.
• Over 3 years, Tax Provisions stood at -$308520.0 in 2015, then soared by 803.3% to $2.2 million in 2018, then slumped by 104.04% to -$87764.0 in 2019.
• Per Business Quant data, the three most recent Tax Provisions figures were -$87764.0 in Q4 2019, -$106771.0 in Q2 2019, and -$62800.0 in Q1 2019.